SCHEMBL22030544

SCHEMBL22030544

CO[C@@H]1OC(C(=O)O)[C@@H](O)C(O[C@@H]2OC[C@@H](O)C(O)C2O)C1O[C@@H]1OC(CO)[C@H](O)C(O)C1O

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ FGF1 P05230 2/20 0.47
▸ LGALS9 O00182 1/20 0.42
▸ LGALS1 P09382 1/20 0.42
▸ LGALS3 P17931 1/20 0.42
▸ LGALS7; LGALS7B P47929 1/20 0.42
▸ CRHBP P24387 2/20 0.41
▸ CRHR2 Q13324 2/20 0.41
▸ LGALS8 O00214 2/20 0.40
▸ PTPN1 P18031 1/20 0.40
▸ IGF2R P11717 1/20 0.39
▸ MAPT P10636 1/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ STAT3 P40763 2/20 0.37
▸ TOP1 P11387 2/20 0.37
▸ GJA1 P17302 1/20 0.37
▸ GJB2 P29033 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15393754 1.00 FGF1 (0.47) FGF1LGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL16508406 1.00 FGF1 (0.47) FGF1LGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL10014358 1.00 FGF1 (0.47) FGF1LGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL16500690 1.00 FGF1 (0.47) FGF1LGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL14255515 0.91 LGALS3 (0.47) FGF1LGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL13560177 0.91 LGALS3 (0.47) FGF1LGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL13867741 0.91 LGALS3 (0.47) FGF1LGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL13559836 0.91 LGALS3 (0.47) FGF1LGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL13560166 0.91 LGALS3 (0.47) FGF1LGALS9LGALS1LGALS3LGALS7; LGALS7B
SCHEMBL13559835 0.91 LGALS3 (0.47) FGF1LGALS9LGALS1LGALS3LGALS7; LGALS7B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200164065-A1 TRITERPENE SAPONIN ANALOGUES ADJUVANCE TECHNOLOGIES, INC. (US) 2020-05-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200164065-A1 TRITERPENE SAPONIN ANALOGUES LSS, NFATC1, PGGT1B FGF1 4700/4885LGALS9 1043/4885LGALS1 530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback